Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 16;2(8):1308-1312.
doi: 10.34067/KID.0002432021. eCollection 2021 Aug 26.

Bleeding Complications of Percutaneous Kidney Biopsy: Does Gender Matter?

Aksharaa Anpalahan  1 , Eva Malacova  2 , Katharine Hegerty  3 , Andrew Malett  4   5 , Dwarakanathan Ranganathan  1 , Helen G Healy  1   5   6 , Pedro Henrique Franca Gois  1   5   6
Affiliations

Bleeding Complications of Percutaneous Kidney Biopsy: Does Gender Matter?

Aksharaa Anpalahan et al. Kidney360. .

Abstract

The incidence of bleeding complications after percutaneous kidney biopsies is low.Female sex may be associated with a greater risk for bleeding complications after percutaneous kidney biopsies.This association and the plausible mechanisms require further evaluation in prospective study.

Keywords: biopsy; bleeding complications; clinical nephrology; nephrectomy; percutaneous kidney biopsy; predictors.

PubMed Disclaimer

Conflict of interest statement

P.H.F. Gois reports having consultancy agreements with, and receiving honoraria from Alexion Pharmaceuticals (for serving on a board committee for atypical hemolytic syndrome), and serving as a reviewer editor for Frontiers in Physiology – Renal and Epithelial Physiology and as a section editor for International Journal of Environmental Research and Public Health. H.G. Healy reports receiving honoraria from Amgen Australia; receiving the research funding from Amgen Australia, Bristol-Myers Squibb Pharmaceuticals, Genzyme International, and Novartis Pharmaceuticals Ltd. Australia; serving as the chief investigator of Chronic Kidney Disease Centre of Research Excellence, cochair of Chronic Kidney Disease Queensland, subeditor of Frontiers in Physiology – Renal and Epithelial Physiology, and director for Kidney Research Foundation. A. Mallett reports serving as the local site trial investigator for Achillion, Dicerna, Novotech, Reata, and Sanofi-Genzyme; having a Metro North Hospital and Health Service Clinical Research Fellowship and Royal Australasian College of Physicians Jacquot Research Establishment Fellowship; serving as a scientific advisor for, or member of, Otsuka; and receiving research funding from Otsuka and Sanofi-Genzyme. All remaining authors have nothing to disclose.

References

    1. Hogan JJ, Mocanu M, Berns JS: The native kidney biopsy: Update and evidence for best practice. Clin J Am Soc Nephrol 11: 354–362, 2016. 10.2215/CJN.05750515 - DOI - PMC - PubMed
    1. Lim C, Tan H, Tan C, Healy H, Choo J, Gois PHF: Desmopressin acetate to prevent bleeding in percutaneous kidney biopsy: A systematic review. Intern Med J 51: 571–579, 2021. 10.1111/imj.14774 - DOI - PubMed
    1. Pombas B, Rodríguez E, Sánchez J, Radosevic A, Gimeno J, Busto M, Barrios C, Sans L, Pascual J, Soler MJ: Risk factors associated with major complications after ultrasound-guided percutaneous renal biopsy of native kidneys. Kidney Blood Press Res 45: 122–130, 2020. 10.1159/000504544 - DOI - PubMed
    1. Manno C, Strippoli GF, Arnesano L, Bonifati C, Campobasso N, Gesualdo L, Schena FP: Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 66: 1570–1577, 2004. 10.1111/j.1523-1755.2004.00922.x - DOI - PubMed
    1. Monahan H, Gunderson T, Greene E, Schmit G, Atwell T, Schmitz J: Risk factors associated with significant bleeding events after ultrasound-guided percutaneous native renal biopsies: A review of 2204 cases. Abdom Radiol (NY) 44: 2316–2322, 2019. 10.1007/s00261-019-01962-z - DOI - PubMed